Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models

Cathy C. Zhang, Zhengming Yan, Qing Zong, +7

Stem Cells Translational Medicine

Breast OncologyCell DeathCancer BiologyTumor BiologyMolecular Pharmacology +16

[18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells

Cathy C. Zhang, Zhengming Yan, Wenlin Li, +15

Clinical Cancer Research

PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity

Cathy C. Zhang, Zhengming Yan, Qin Zhang, +15

Clinical Cancer Research

Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models

Cathy C. Zhang, Adam Pavlı́c̀ek, Qin Zhang, +13

Clinical Cancer Research

PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts

Cathy Zhang, Zhengming Yan, Cory L. Painter, +13

Clinical Cancer Research

A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies

Shu‐Hui Liu, Yin Gu, Bernadette Pascual, +25

Blood Advances

Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging

Peter J. O’Brien, Michelle Lee, Mary E. Spilker, +7

Cancer & Metabolism

Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models

Cathy Zhang, Zhengming Yan, Maria E. Arango, +2

Clinical Cancer Research

A DNA-Methylation-Driven Genes Based Prognostic Signature Reveals Immune Microenvironment in Pancreatic Cancer

Mingjia Xiao, Xiang-Jing Liang, Zhengming Yan, +9

Frontiers in Immunology

Tumor BiologyOncologyPancreatic CancerMedicineEpigenetic Change +11

Therapeutic Potential of CUDC-907 (Fimepinostat) for Hepatocarcinoma Treatment Revealed by Tumor Spheroids-Based Drug Screening

Wei Liao, Wanren Yang, Jiecheng Xu, +13

Frontiers in Pharmacology